COST-JUSTIFICATION OF A CLINICAL PHARMACIST-MANAGED ANTICOAGULATION CLINIC

被引：89

作者：

GRAY, DR

GARABEDIANRUFFALO, SM

CHRETIEN, SD

机构：

[1] GEORGE WASHINGTON UNIV HOSP,WASHINGTON,DC 20037

[2] VET ADM MED CTR,CLIN PHARM SECT,LONG BEACH,CA 90822

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1985年 / 19卷 / 7-8期

关键词：

D O I：

10.1177/106002808501900716

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：575 / 580

页数：6

共 18 条

[1] HEMORRHAGIC COMPLICATIONS OF ANTICOAGULANT THERAPY [J].

COON, WW ;

WILLIS, PW .

ARCHIVES OF INTERNAL MEDICINE, 1974, 133 (03) :386-392

[2] MANAGEMENT OF ANTICOAGULATION IN OUTPATIENTS - EXPERIENCE WITH AN ANTICOAGULATION SERVICE IN A MUNICIPAL HOSPITAL SETTING [J].

DAVIS, FB ;

ESTRUCH, MT ;

SAMSONCORVERA, EB ;

VOIGT, GC ;

TOBIN, JD .

ARCHIVES OF INTERNAL MEDICINE, 1977, 137 (02) :197-202

[3] THERAPEUTIC CONTROL OF ANTICOAGULANT TREATMENT [J].

DUXBURY, BM .

BRITISH MEDICAL JOURNAL, 1982, 284 (6317) :702-704

[4]

EISENBERG L, 1977, DRUG THER, V7, P60

[5] RETROSPECTIVE EVALUATION OF A PHARMACIST-MANAGED WARFARIN ANTICOAGULATION CLINIC [J].

GARABEDIANRUFFALO, SM ;

GRAY, DR ;

SAX, MJ ;

RUFFALO, RL .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1985, 42 (02) :304-308

[6]

Gray D, 1983, QRB Qual Rev Bull, V9, P6

[7] PROTECTING MEDICAL COMMONS - WHO IS RESPONSIBLE [J].

HIATT, HH .

NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (05) :235-241

[8]

LOELIGER EA, 1975, MEYLERS SIDE EFFECTS, V8, P764

[9] COST-BENEFIT AND COST-EFFECTIVENESS - METHODOLOGIES FOR EVALUATING INNOVATIVE PHARMACEUTICAL SERVICES [J].

MCGHAN, WF ;

ROWLAND, CR ;

BOOTMAN, JL .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1978, 35 (02) :133-140

[10]

OREILLY RA, 1970, PHARMACOL REV, V22, P35

← 1 2 →